FDA-approved nasal spray therapy for treatment-resistant depression in a comfortable, supervised clinical setting.
If you are searching for a certified 'Spravato provider near me' in New Jersey, Dr. Ritesh Amin's Edison clinic is an officially certified Spravato REMS (Risk Evaluation and Mitigation Strategy) center. Spravato (esketamine) is an FDA-approved prescription nasal spray administered under clinical supervision for adults with treatment-resistant depression.
Unlike traditional antidepressants that take 4 to 8 weeks to alter serotonin levels, Spravato targets NMDA glutamate receptors, triggering rapid synaptogenesis—the formation of new neural connections within hours to days. This innovative mechanism of action delivers rapid symptom relief for patients who have suffered from unrelenting depressive episodes.
Spravato is self-administered via a specialized nasal spray device in our comfortable, private treatment suites under physician supervision. Patients relax in reclining chairs for a 2-hour observation period while our medical team monitors blood pressure and well-being. Because Spravato is FDA-approved, it is widely covered by Medicare and commercial insurance.
Reactivates dormant neural circuits in the prefrontal cortex.
Promotes enduring synaptic neuroplasticity without chemical tolerance.
Zero anesthesia, zero memory loss, and no post-session recovery downtime.
Under the direct leadership of Dr. Ritesh Amin, MD, every treatment protocol is individualized to your anatomical mapping and diagnostic history.
Helpful information about TMS therapy, insurance coverage, candidate qualification, and what to expect.
You do not have to struggle in silence with treatment-resistant depression or anxiety. Dr. Ritesh Amin and our dedicated team are ready to help you recover.